Skip navigation
Universidade Federal da Bahia |
Repositório Institucional da UFBA
Use este identificador para citar ou linkar para este item: https://repositorio.ufba.br/handle/ri/5845
Tipo: Artigo de Periódico
Título: Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: a comparison between sustained virological responders and non-responders
Título(s) alternativo(s): Liver International
Autor(es): Carneiro, Valdirene Leão
Lemaire, Denise Carneiro
Bendicho, Maria Teresita Del Niño Jesus Fernandez
Souza, Sabrina L.
Cavalcante, Lourianne Nascimento
Angelo, Ana Luiza Dias
Freire, Songeli Menezes
Mendes, Carlos Maurício Cardeal
Santana, Nelma Pereira de
Lyra, Luiz Guilherme Costa
Autor(es): Carneiro, Valdirene Leão
Lemaire, Denise Carneiro
Bendicho, Maria Teresita Del Niño Jesus Fernandez
Souza, Sabrina L.
Cavalcante, Lourianne Nascimento
Angelo, Ana Luiza Dias
Freire, Songeli Menezes
Mendes, Carlos Maurício Cardeal
Santana, Nelma Pereira de
Lyra, Luiz Guilherme Costa
Abstract: Background/Aims: Killer cell immunoglobulin-like receptors (KIR) are involved in the activation/inhibition of NK cells through an interaction with HLA class I molecules on target cells. Our study aimed to evaluate the association between KIR gene polymorphisms and the response of patients with CHC to antiviral therapy. Methods: We compared the frequency of KIR genes, as well as that of compound KIR/HLA-C genotypes, between groups of patients with CHC who presented a sustained virological response (n = 66) and who were non-responders to a combination of pegylated or standard interferon and ribavirin (n = 101). KIR and HLA-C genotyping were performed using commercial kits. Results: We detected a greater frequency of the KIR2DL5 gene among non-responders to antiviral therapy compared with sustained virological responders (68.3 vs. 40.9%) (Po0.001). We used multiple logistic regression analysis to determine the association between therapy response and the presence of KIR2DL5, after a control for potentially confounding variables (genotype, alcohol, fibrosis, gender, age, ethnic background and route of HCV infection). The results confirmed the strong association between the presence of KIR2DL5 and the non-response to antiviral treatment (P = 0.001). Conclusions: Host genetic factors may be associated with a non-response to antiviral therapy. KIR2DL5 is a candidate gene involved in immunomodulation associated with non-response to antiviral therapy.
Palavras-chave: antiviral therapy
chronic hepatitis C
interferon – KIR
natural killer cells
Editora / Evento / Instituição: John Wiley & Sons A/S
URI: http://www.repositorio.ufba.br/ri/handle/ri/5845
Data do documento: Abr-2010
Aparece nas coleções:Artigo Publicado em Periódico (ICS)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
(13)j.1478-3231.2010.02212.x.pdf
  Restricted Access
182,5 kBAdobe PDFVisualizar/Abrir Solicitar uma cópia
Mostrar registro completo do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.